Article
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
PLoS biology - 1 Nov 2019
Sriram Krishna, Moyung Kevin, Corriden Ross, Carter Hannah, Insel Paul A
Abstract excerpt
G protein-coupled receptors (GPCRs) are the most widely targeted gene family for Food and Drug Administration (FDA)-approved drugs. To assess possible roles for GPCRs in cancer, we analyzed The Cancer Genome Atlas (TCGA) data for mRNA expression, mutations, and copy number variation (CNV) in 20 categories and 45 subtypes of solid tumors and quantified differential expression (DE) of GPCRs by comparing tumors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
